Nitrendipine and Superoxide Dismutase in Ischemic Renal Injury

The effect of the Ca entry blocker nitrendipine, the untioxidant superoxide dismutase (SOD), and a combination cf nitrendipine und superoxide dismutase on postischemic renal function was studied in four groups (n = 24) of rats. The rats in group I (n = 6) were the ischemic control and received 10 mL...

Full description

Saved in:
Bibliographic Details
Published inRenal failure Vol. 16; no. 6; pp. 697 - 705
Main Authors Jacobsen, Wayne K., Schell, Randall M., Matsumura, Jerry S., Cole, Daniel J., Stier, Gary R., Martin, Robert D., Fandrich, Bryan L.
Format Journal Article
LanguageEnglish
Published Colchester Informa UK Ltd 01.01.1994
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The effect of the Ca entry blocker nitrendipine, the untioxidant superoxide dismutase (SOD), and a combination cf nitrendipine und superoxide dismutase on postischemic renal function was studied in four groups (n = 24) of rats. The rats in group I (n = 6) were the ischemic control and received 10 mL of 0.9% NaCl. Group II (n = 6) received SOD 7.0 mg/kg. Group III (n = 6) received nitrendipine 1 mg/kg. Group IV (n = 6) received nitrendipine 1 mg/kg and SOD 7 mg/kg, After administration, both kidneys were rendered ischemic by crossclamping the renal vessels for 60 min. Comparison of 24-h creatinine clearance (CCr) for 3 days after reversal og ischemia revealed: (a) nitrendipine alone was the most effective in preserving renal function (p <.05); (b) SOD provided some degree of improvement, but only on day 3 (p <.05); (c) a similar result was detected using a combination of nitrendipine and SOD (p <,05); (d) there was no significant difference between SOD and nitrendipine nor between SOD and the combination of nitrendipine/SOD; (e) there was a significant improvement with nitrendipine when compared to the combination of nitrendipine/SOD (p <. 05).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0886-022X
1525-6049
DOI:10.3109/08860229409044899